Corbus Pharmaceuticals Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 858.74 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 284.50K shares, a 143.16% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 574.24K shares, a 3.87% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 7.13K shares, a 35.71% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 1.88K shares, a 79.03% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 723.38K shares, a 188.15% increase from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 251.04K shares, a 13.78% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 291.15K shares, a 57.24% increase from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 185.17K shares, a 24.66% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 284.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 858.74K shares 10-Q · filed 2026-08-06 | 865.86K shares derived: sum of 3 quarters · filed 2026-08-06 | 867.74K shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 574.24K shares 10-Q · filed 2026-05-12 | 581.36K shares derived: sum of 2 quarters · filed 2026-05-12 | 583.24K shares derived: sum of 3 quarters · filed 2026-05-12 | 700.24K shares derived: sum of 4 quarters · filed 2026-05-12 | |
| 2025-12-31 | 7.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 9.00K shares derived: sum of 2 quarters · filed 2026-03-09 | 126.00K shares derived: sum of 3 quarters · filed 2026-03-09 | 723.38K shares 10-K · filed 2026-03-09 | |
| 2025-09-30 | 1.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 118.88K shares derived: sum of 2 quarters · filed 2025-11-12 | 716.25K shares 10-Q · filed 2025-11-12 | 721.50K shares derived: sum of 4 quarters · filed 2025-11-12 | |
| 2025-06-30 | 117.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 714.38K shares 10-Q · filed 2025-08-05 | 719.63K shares derived: sum of 3 quarters · filed 2025-08-05 | 728.57K shares derived: sum of 4 quarters · filed 2025-08-05 | |
| 2025-03-31 | 597.38K shares 10-Q · filed 2025-05-06 | 602.63K shares derived: sum of 2 quarters · filed 2025-05-06 | 611.57K shares derived: sum of 3 quarters · filed 2025-05-06 | 648.30K shares derived: sum of 4 quarters · filed 2025-05-06 | |
| 2024-12-31 | 5.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 14.19K shares derived: sum of 2 quarters · filed 2025-03-11 | 50.92K shares derived: sum of 3 quarters · filed 2025-03-11 | 251.04K shares 10-K · filed 2025-03-11 | |
| 2024-09-30 | 8.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 45.67K shares derived: sum of 2 quarters · filed 2024-11-07 | 245.79K shares 10-Q · filed 2024-11-07 | 248.29K shares derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | 36.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 236.85K shares 10-Q · filed 2024-08-06 | 239.35K shares derived: sum of 3 quarters · filed 2024-08-06 | 242.27K shares derived: sum of 4 quarters · filed 2024-08-06 | |
| 2024-03-31 | 200.12K shares 10-Q · filed 2024-05-07 | 202.62K shares derived: sum of 2 quarters · filed 2024-05-07 | 205.54K shares derived: sum of 3 quarters · filed 2024-05-07 | 244.30K shares derived: sum of 4 quarters · filed 2024-05-07 | |
| 2023-12-31 | 2.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 5.42K shares derived: sum of 2 quarters · filed 2024-03-12 | 44.18K shares derived: sum of 3 quarters · filed 2024-03-12 | 291.15K shares 10-K · filed 2024-03-12 | |
| 2023-09-30 | 2.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 41.68K shares derived: sum of 2 quarters · filed 2023-11-07 | 288.65K shares 10-Q · filed 2023-11-07 | -4.82M shares derived: sum of 4 quarters · filed 2024-03-12 | |
| 2023-06-30 | 38.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 285.73K shares 10-Q · filed 2023-08-08 | -4.83M shares derived: sum of 3 quarters · filed 2024-03-12 | -4.62M shares derived: sum of 4 quarters · filed 2024-03-12 | |
| 2023-03-31 | 246.97K shares 10-Q · filed 2023-05-09 | -4.87M shares derived: sum of 2 quarters · filed 2024-03-12 | -4.65M shares derived: sum of 3 quarters · filed 2024-03-12 | -4.20M shares derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-12-31 | -5.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -4.90M shares derived: sum of 2 quarters · filed 2024-03-12 | -4.45M shares derived: sum of 3 quarters · filed 2024-03-12 | 185.17K shares 10-K · filed 2024-03-12 | |
| 2022-09-30 | 212.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 662.49K shares derived: sum of 2 quarters · filed 2022-11-08 | 5.30M shares 10-Q · filed 2022-11-08 | -1.24M shares derived: sum of 4 quarters · filed 2023-03-07 | |
| 2022-06-30 | 450.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 5.09M shares 10-Q · filed 2022-08-09 | -1.46M shares derived: sum of 3 quarters · filed 2023-03-07 | -1.28M shares derived: sum of 4 quarters · filed 2023-03-07 | |
| 2022-03-31 | 4.64M shares 10-Q · filed 2022-05-10 | -1.91M shares derived: sum of 2 quarters · filed 2023-03-07 | -1.73M shares derived: sum of 3 quarters · filed 2023-03-07 | -1.11M shares derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-12-31 | -6.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -6.37M shares derived: sum of 2 quarters · filed 2023-03-07 | -5.75M shares derived: sum of 3 quarters · filed 2023-03-07 | 245.79K shares 10-K · filed 2023-03-07 | 7.37M shares 10-K · filed 2022-03-08 |
| 2021-09-30 | 175.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 792.00K shares derived: sum of 2 quarters · filed 2021-11-12 | 6.79M shares 10-Q · filed 2021-11-12 | 6.93M shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-06-30 | 617.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 6.61M shares 10-Q · filed 2021-08-12 | 6.76M shares derived: sum of 3 quarters · filed 2022-03-08 | 7.27M shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-03-31 | 6.00M shares 10-Q · filed 2021-05-13 | 6.14M shares derived: sum of 2 quarters · filed 2022-03-08 | 6.65M shares derived: sum of 3 quarters · filed 2022-03-08 | 7.13M shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-12-31 | 142.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 653.00K shares derived: sum of 2 quarters · filed 2022-03-08 | 1.13M shares derived: sum of 3 quarters · filed 2022-03-08 | 4.54M shares 10-K · filed 2022-03-08 | |
| 2020-09-30 | 511.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | 989.00K shares derived: sum of 2 quarters · filed 2020-11-09 | 4.39M shares 10-Q · filed 2020-11-09 | 4.88M shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-06-30 | 478.00K shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | 3.88M shares 10-Q/A · filed 2020-08-31 | 4.37M shares derived: sum of 3 quarters · filed 2021-03-15 | 4.93M shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-03-31 | 3.41M shares 10-Q · filed 2020-05-11 | 3.89M shares derived: sum of 2 quarters · filed 2021-03-15 | 4.45M shares derived: sum of 3 quarters · filed 2021-03-15 | 5.10M shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-12-31 | 485.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 1.04M shares derived: sum of 2 quarters · filed 2021-03-15 | 1.70M shares derived: sum of 3 quarters · filed 2021-03-15 | 4.13M shares 10-K · filed 2021-03-15 | |
| 2019-09-30 | 560.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 1.21M shares derived: sum of 2 quarters · filed 2019-11-07 | 3.64M shares 10-Q · filed 2019-11-07 | 3.88M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-06-30 | 652.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 3.08M shares 10-Q · filed 2019-08-08 | 3.32M shares derived: sum of 3 quarters · filed 2020-03-16 | 3.47M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-03-31 | 2.43M shares 10-Q · filed 2019-05-09 | 2.67M shares derived: sum of 2 quarters · filed 2020-03-16 | 2.82M shares derived: sum of 3 quarters · filed 2020-03-16 | 3.23M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-12-31 | 240.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 390.00K shares derived: sum of 2 quarters · filed 2020-03-16 | 804.00K shares derived: sum of 3 quarters · filed 2020-03-16 | 2.38M shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 564.00K shares derived: sum of 2 quarters · filed 2018-11-08 | 2.14M shares 10-Q · filed 2018-11-08 | 2.40M shares derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-06-30 | 414.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 1.99M shares 10-Q · filed 2018-08-08 | 2.25M shares derived: sum of 3 quarters · filed 2019-03-12 | 2.34M shares derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-03-31 | 1.57M shares 10-Q · filed 2018-05-10 | 1.83M shares derived: sum of 2 quarters · filed 2019-03-12 | 1.93M shares derived: sum of 3 quarters · filed 2019-03-12 | 2.19M shares derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-12-31 | 258.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 353.50K shares derived: sum of 2 quarters · filed 2019-03-12 | 618.00K shares derived: sum of 3 quarters · filed 2019-03-12 | 1.68M shares 10-K · filed 2019-03-12 | |
| 2017-09-30 | 95.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 359.50K shares derived: sum of 2 quarters · filed 2017-11-08 | 1.42M shares 10-Q · filed 2017-11-08 | 2.18M shares derived: sum of 4 quarters · filed 2018-03-12 | |
| 2017-06-30 | 264.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 1.33M shares 10-Q · filed 2017-08-09 | 2.08M shares derived: sum of 3 quarters · filed 2018-03-12 | 2.72M shares derived: sum of 4 quarters · filed 2018-03-12 | |
| 2017-03-31 | 1.06M shares 10-Q · filed 2017-05-09 | 1.82M shares derived: sum of 2 quarters · filed 2018-03-12 | 2.46M shares derived: sum of 3 quarters · filed 2018-03-12 | 2.89M shares derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-12-31 | 755.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 1.40M shares derived: sum of 2 quarters · filed 2018-03-12 | 1.82M shares derived: sum of 3 quarters · filed 2018-03-12 | 3.02M shares 10-K · filed 2018-03-12 | |
| 2016-09-30 | 640.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 1.07M shares derived: sum of 2 quarters · filed 2016-11-10 | 2.27M shares 10-Q · filed 2016-11-10 | 2.54M shares derived: sum of 4 quarters · filed 2017-03-08 | |
| 2016-06-30 | 430.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | 1.63M shares 10-Q · filed 2016-08-12 | 1.90M shares derived: sum of 3 quarters · filed 2017-03-08 | 2.03M shares derived: sum of 4 quarters · filed 2017-03-08 | |
| 2016-03-31 | 1.20M shares 10-Q · filed 2016-05-13 | 1.47M shares derived: sum of 2 quarters · filed 2017-03-08 | 1.60M shares derived: sum of 3 quarters · filed 2017-03-08 | 1.65M shares derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-12-31 | 277.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | 407.50K shares derived: sum of 2 quarters · filed 2017-03-08 | 455.00K shares derived: sum of 3 quarters · filed 2017-03-08 | 600.00K shares 10-K · filed 2017-03-08 | |
| 2015-09-30 | 130.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 177.50K shares derived: sum of 2 quarters · filed 2015-11-10 | 322.50K shares 10-Q · filed 2015-11-10 | 1.67M shares derived: sum of 4 quarters · filed 2016-03-28 | |
| 2015-06-30 | 47.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 192.50K shares 10-Q · filed 2015-08-13 | 1.54M shares derived: sum of 3 quarters · filed 2016-03-28 | ||
| 2015-03-31 | 145.00K shares 10-Q · filed 2015-05-13 | 1.49M shares derived: sum of 2 quarters · filed 2016-03-28 | |||
| 2014-12-31 | 1.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | 3.05M shares 10-K · filed 2016-03-28 | |||
| 2014-09-30 | 1.70M shares 10-Q · filed 2014-11-13 | ||||
| 2013-12-31 | 105.62K shares 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |